Assessing the contribution of the immune reconstitution inflammatory syndrome to mortality in developing country antiretroviral therapy programs

Clinical Infectious Diseases

Volumn 49, Issue 6, 2009, Pages 973-975

  Davies, Mary Ann ^a,e   Meintjes, Graeme ^b,c,d  

^a School of Public Health and Family Medicine   (South Africa)

^b Institute of Infectious Disease and Molecular Medicine   (South Africa)

^c UNIVERSITY OF CAPE TOWN   (South Africa)

^d GF Jooste Hospital   (South Africa)

^e UNIVERSITY OF CAPE TOWN   (South Africa)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; FLUCONAZOLE;

CAUSE OF DEATH; CRYPTOCOCCAL MENINGITIS; DEVELOPING COUNTRY; HEALTH CARE ACCESS; HEALTH PROGRAM; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME; KAPOSI SARCOMA; MORTALITY; NOTE; OPPORTUNISTIC INFECTION; PRIORITY JOURNAL; TUBERCULOSIS;

AIDS-RELATED OPPORTUNISTIC INFECTIONS; ANTI-RETROVIRAL AGENTS; DEVELOPING COUNTRIES; HIV INFECTIONS; HUMANS; IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME; RESEARCH DESIGN; RISK FACTORS;

EID: 70049103387     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/605501     Document Type: Note

References (17)

1. World Health Organization, United Nations Childrens Fund, and the Joint United Nations Programme on HIV/AIDS. Towards universal access: scaling up priority HIV/AIDS interventions in the health sector. Available at: http://www.who.int/ hiv/mediacentre/2008progressreport/en/ index.html. Accessed 5 December 2008.
2. Lawn SD, Harries AD, Anglaret X, Myer L, Wood R: Early mortality among adults accessing antiretroviral treatment programmes in sub-Saharan Africa. AIDS 2008; 22: 1897-1908
3. Braitstein P, Brinkhof' MW, Dabis F, et al. Mortality of HIV-1-infected patients in the first year of antiretroviral therapy: comparison between low-income and high-income countries. Lancet 2006;367:817-824
4. French MA. HIV/AIDS: immune reconstitution inflammatory syndrome: a reappraisal. Clin Infect Dis 2009;48:101-107
5. Lawn SD, Lipman MC, Easterbrook PJ: Immune reconstitution disease associated with mycobacterial infections. Curr Opin HIV AIDS 2008;3:425-431
6. Meintjes G, Lawn SD, Scano F, et al. Tuberculosis-associated immune reconstitution inflammatory syndrome: case definitions for use in resource-limited settings. Lancet Infect Dis 2008;8:516-523 (Pubitemid 352005824)
7. French MA, Price P, Stone SF. Immune restoration disease after antiretroviral therapy. AIDS 2004; 18:1615-1627 (Pubitemid 39095778)
8. Castelnuovo B, Manabe YC, Kiragga A, Kamya M, Easterbrook P, Kambugu A. Causespecific mortality and the contribution of immune reconstitution inflammatory syndrome in the first three years after antiretroviral therapy initiation in an urban African cohort. Clin Infect Dis 2009;49:965-972 (in this issue).
9. Lawn SD, Bekker LG, Miller RF. Immune reconstitution disease associated with mycobacterial infections in HIV-infected individuals receiving antiretrovirals. Lancet Infect Dis 2005; 5:361-373
10. Dhasmana DJ, Dheda K, Ravn P, Wilkinson RJ, Meintjes G. Immune reconstitution inflammatory syndrome in HIV-infected patients receiving antiretroviral therapy: pathogenesis, clinical manifestations and management. Drugs 2008;68:191-208.
11. Shelbume SA, Montes M, Hamill RJ. Immune reconstitution inflammatory syndrome: more answers, more questions. J Antimicrob Chemother 2006;57:167-170 (Pubitemid 43160154)
12. Bourgarit A, Carcelain G, Martinez V, et al. Explosion of tuberculin-specific Th 1-responses induces immune restoration syndrome in tuberculosis and HIV co-infected patients. AIDS 2006;20:F1-F7.
13. Lawn SD, Wainwright H, Orrell C. Fatal unmasking tuberculosis immune reconstitution disease with bronchiolitis obliterans organizing pneumonia: the role of macrophages. AIDS 2009;23:143-145
14. Bower M, Nelson M, Young AM, et al. Immune reconstitution inflammatory syndrome associated with Kaposi's sarcoma. J Clin Oncol 2005;23:5224-5228 (Pubitemid 46224033)
15. Martin J, Laker M, Clutter D, et al. Kaposi's sarcoma-associated immune reconstitution inflammatory syndrome in Africa: initial findings from a prospective evaluation [abstract 31]. In: Program and abstracts of the 16th Conference on Retroviruses and Opportunistic Infections (Montreal, Canada). 2009.
16. Lawn SD, Bekker LG, Myer L, Orrell C, Wood R. Cryptococcocal immune reconstitution disease: a major cause of early mortality in a South African antiretroviral programme. AIDS 2005; 19:2050-2052 (Pubitemid 41669038)
17. Jarvis JN, Lawn SD, Vogt M, Bangani N, Wood R, Harrison TS. Screening for cryptococcal antigenemia in patients accessing an antiretroviral treatment program in South Africa. Clin Infect Dis 2009;48:856-862